[14] examined the efficacy of a point-of-care C-reactive protein (CRP) finger-prick testing as a diagnostic method for TB among people who are HIV positive and have CD4 levels equal to or less than 340 cells/ml. The gene discussed is CD4; the disease is tuberculosis.